Dissemination of carbapenemase-producing Enterobacterales in the community of Rawalpindi, Pakistan

被引:18
|
作者
Habib, Amina [1 ]
Lo, Stephane [2 ,3 ]
Villageois-Tran, Khanh [2 ,4 ]
Petitjean, Marie [2 ]
Malik, Shaheen Akhtar [5 ]
Armand-Lefevre, Laurence [2 ,3 ]
Ruppe, Etienne [2 ,3 ]
Zahra, Rabaab [1 ]
机构
[1] Quaid i Azam Univ, Fac Biol Sci, Dept Microbiol, Islamabad, Pakistan
[2] Univ Paris, INSERM, IAME, Paris, France
[3] Hop Bichat Claude Bernard, AP HP, Lab Bacteriol, Paris, France
[4] Hop Beaujon, AP HP, Lab Bacteriol, Clichy, France
[5] Benazir Bhutto Hosp, Accid & Emergency Dept, Rawalpindi, Pakistan
来源
PLOS ONE | 2022年 / 17卷 / 07期
关键词
ESCHERICHIA-COLI; RESISTANT ENTEROBACTERIACEAE; MOLECULAR CHARACTERIZATION; NDM-1; CARBAPENEMASE; PREVALENCE; HEALTH; ENVIRONMENT; MECHANISMS; ABUNDANCE; ALIGNMENT;
D O I
10.1371/journal.pone.0270707
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Carbapenems are considered last-line beta-lactams for the treatment of infections caused by multidrug-resistant Gram-negative bacteria. However, their activity is compromised by the rising prevalence of carbapenemase-producing Enterobacterales (CPE), which are especially marked in the Indian subcontinent. In Pakistan, previous reports have warned about the possible spread of CPE in the community, but data are still partial. This study was carried out to analyse the prevalence of CPE, the genetic characterisation, and phylogenetic links among the spreading CPE in the community. In this cohort study, we collected 306 rectal swabs from patients visiting Benazir Bhutto hospital, Rawalpindi. CPEs were screened by using ertapenem-supplemented MacConkey agar. Identification was performed by using conventional biochemical tests, and genomes were sequenced using Illumina chemistry. Antibiotic resistance genes, plasmid incompatibility groups, and Escherichia coli phylogroups were determined in silico. Sequence types were determined by using MLST tool. The prevalence of CPE carriage observed was 14.4% (44/306 samples). The most common carbapenemase-encoding gene was bla-(NDM-5) (n = 58) followed by bla(NDM-1) (n = 7), bla(NDM) (non-assigned variant, n = 4), bla(OXA-181) (n = 3), bla(OXA-232) (n = 3) and bla(NDM-7) (n = 1). Most of the CPE were E. coli (55/64, 86%), and the genomic analysis revealed a pauciclonal diffusion of E. coli with ST167 (n = 14), 405 (n = 10), 940 (n = 8), 648 (n = 6) and 617 (n = 5). We obtained a second sample from 94 patients during their hospital stay in whom carriage was negative at admission and found that 7 (7.4%) acquired a CPE. Our results indicate that the prevalence of CPE carriage in the Pakistani urban community was high and driven by the dissemination of some E. coli clones, with ST167 being the most frequent. The high CPE carriage in the community poses a serious public health threat and calls for implementation of adequate preventive measures.
引用
收藏
页数:20
相关论文
共 50 条
  • [21] Carbapenemase-producing Enterobacterales infections: recent advances in diagnosis and treatment
    Lee, Yu-Lin
    Chen, Hsien-Meng
    Hii, Ing-Moi
    Hsueh, Po-Ren
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2022, 59 (02)
  • [22] Carbapenemase-producing Enterobacterales in hospital drains in Southern Ontario, Canada
    Jamal, A. J.
    Mataseje, L. F.
    Brown, K. A.
    Katz, K.
    Johnstone, J.
    Muller, M. P.
    Allen, V. G.
    Borgia, S.
    Boyd, D. A.
    Ciccotelli, W.
    Delibasic, K.
    Fisman, D. N.
    Khan, N.
    Leis, J. A.
    Li, A. X.
    Mehta, M.
    Ng, W.
    Pantelidis, R.
    Paterson, A.
    Pikula, G.
    Sawicki, R.
    Schmidt, S.
    Souto, R.
    Tang, L.
    Thomas, C.
    McGeer, A. J.
    Mulvey, M. R.
    JOURNAL OF HOSPITAL INFECTION, 2020, 106 (04) : 820 - 827
  • [23] Epidemiology of carbapenemase-producing Enterobacterales in the Middle East: a systematic review
    Touati, Abdelaziz
    Mairi, Assia
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2020, 18 (03) : 241 - 250
  • [24] Molecular epidemiology of carbapenemase-producing Enterobacterales in Finland, 2012–2018
    Kati Räisänen
    Outi Lyytikäinen
    Jari Kauranen
    Eveliina Tarkka
    Benita Forsblom-Helander
    Juha O. Grönroos
    Risto Vuento
    Dinah Arifulla
    Emmi Sarvikivi
    Saija Toura
    Jari Jalava
    European Journal of Clinical Microbiology & Infectious Diseases, 2020, 39 : 1651 - 1656
  • [25] Carbapenemase-producing Enterobacterales: a challenge for healthcare now and for the next decade
    Patel, Bharat
    Hopkins, Katie L.
    Freeman, Rachel
    Pople, Diane
    Brown, Colin S.
    Robotham, Julie V.
    INFECTION PREVENTION IN PRACTICE, 2020, 2 (03)
  • [26] Bacteremia with Carbapenemase-Producing Enterobacterales in Immunocompromised Patients Colonized with These Bacteria
    Averbuch, Diana
    Moshkovitz, Liya
    Ilan, Shlomi
    Abu Ahmad, Wiessam
    Temper, Violeta
    Strahilevitz, Jacob
    MICROBIAL DRUG RESISTANCE, 2022, 28 (05) : 593 - 600
  • [27] Carbapenemase-producing Enterobacterales infections in COVID-19 patients
    Pintado, Vicente
    Ruiz-Garbajosa, Patricia
    Escudero, Rosa
    Gioia, Francesca
    Herrera, Sabina
    Vizcarra, Pilar
    Fortun, Jesus
    Cobo, Javier
    Martin-Davila, Pilar
    Isabel Morosini, Maria
    Canton, Rafael
    Moreno, Santiago
    INFECTIOUS DISEASES, 2022, 54 (01) : 36 - 45
  • [28] Association of Carbapenemase-Producing Enterobacterales Detected in Stream and Clinical Samples
    Sung, Gyung-Hye
    Kim, Si Hyun
    Park, Eun Hee
    Hwang, Suk Nam
    Kim, Jea-Dong
    Kim, Gyu Ri
    Kim, Eun-Young
    Jeong, Joseph
    Kim, Sunjoo
    Shin, Jeong Hwan
    FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [29] TREATING CARBAPENEMASE-PRODUCING ENTEROBACTERALES UROSEPSIS WITH CEFTAZIDIME/AVIBACTAM IN PREGNANCY
    Kendrick, C.
    Lebedevs, T.
    Hazelton, B.
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2022, 31 : S45 - S45
  • [30] Carbapenemase-producing Enterobacterales: a profound threat to Australian public health
    Flynn, Erin
    Papanicolas, Lito E.
    Anagnostou, Nicholas
    Warner, Morgyn S.
    Rogers, Geraint B.
    MEDICAL JOURNAL OF AUSTRALIA, 2023, 219 (07) : 290 - 292